HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sharon A Meyer Selected Research

Neoplasms (Cancer)

5/2023Lyophilized liposomal formulation of a peptidomimetic-Dox conjugate for HER2 positive breast and lung cancer.
1/2022A pH-sensitive liposome formulation of a peptidomimetic-Dox conjugate for targeting HER2 + cancer.
6/2020(-)-Oleocanthal as a Dual c-MET-COX2 Inhibitor for the Control of Lung Cancer.
1/2020Safety Evaluations of Single Dose of the Olive Secoiridoid S-(-)-Oleocanthal in Swiss Albino Mice.
5/2019(-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence After Primary Tumor Surgical Excision and Neoadjuvant Targeted Therapy in Orthotopic Nude Mouse Models.
2/2019(-)-Oleocanthal Combined with Lapatinib Treatment Synergized against HER-2 Positive Breast Cancer In Vitro and In Vivo.
7/2014Marine natural products-inspired phenylmethylene hydantoins with potent in vitro and in vivo antitumor activities via suppression of Brk and FAK signaling.
11/2012The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sharon A Meyer Research Topics

Disease

8Neoplasms (Cancer)
05/2023 - 11/2012
6Breast Neoplasms (Breast Cancer)
01/2022 - 11/2012
3Prostatic Neoplasms (Prostate Cancer)
02/2023 - 11/2010
2Lung Neoplasms (Lung Cancer)
05/2023 - 06/2020
2Seizures (Absence Seizure)
01/2017 - 09/2005
1Cardiovascular Diseases (Cardiovascular Disease)
01/2020
1Neoplasm Micrometastasis
07/2014
1Anemia
02/2013
1Hepatoblastoma
05/2007
1Hemosiderosis
09/2005

Drug/Important Bio-Agent (IBA)

3Doxorubicin (Adriamycin)FDA LinkGeneric
05/2023 - 11/2012
3Olive OilIBA
06/2020 - 02/2019
3oleocanthalIBA
06/2020 - 02/2019
3cyclonite (RDX)IBA
01/2017 - 09/2005
2LigandsIBA
05/2023 - 01/2022
2PeptidomimeticsIBA
05/2023 - 01/2022
2Proteins (Proteins, Gene)FDA Link
02/2023 - 05/2019
2Lapatinib (GW572016)FDA Link
05/2019 - 02/2019
1Liposomes (Liposome)IBA
05/2023
1Cytotoxins (Cytolysins)IBA
05/2023
1TrehaloseIBA
05/2023
1AlkaloidsIBA
02/2023
1pseurotinIBA
02/2023
1LactamsIBA
02/2023
1Cell Surface ReceptorsIBA
01/2022
1Cadherins (E-Cadherin)IBA
05/2019
1VimentinIBA
05/2019
1Tyrosine Kinase InhibitorsIBA
02/2019
1Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
02/2019
1Focal Adhesion Protein-Tyrosine KinasesIBA
02/2019
1PaxillinIBA
02/2019
1ErbB Receptors (EGF Receptor)IBA
02/2019
1hexahydro- 1- nitroso- 3,5- dinitro- 1,3,5- triazineIBA
01/2017
1HydantoinsIBA
07/2014
1Therapeutic UsesIBA
04/2014
1sipholenol AIBA
04/2014
1EstersIBA
04/2014
1indoleIBA
01/2013
1Diterpene AlkaloidsIBA
01/2013
1CateninsIBA
01/2013
1tremortin (penitrem A)IBA
01/2013
1CeramidesIBA
11/2012
1ceramide glucosyltransferaseIBA
11/2012
1Adenosine Triphosphate (ATP)IBA
11/2010
1alachlorIBA
05/2007
1Cytochrome P-450 CYP3AIBA
05/2007
1Dexamethasone (Maxidex)FDA LinkGeneric
05/2007
1Hemoglobins (Hemoglobin)IBA
09/2005

Therapy/Procedure

3Drug Therapy (Chemotherapy)
05/2023 - 11/2012
3Therapeutics
05/2019 - 07/2014
1Mediterranean Diet
01/2020
1Neoadjuvant Therapy
05/2019
1Radiotherapy
07/2014